Abstract
Background:Abatacept (ABT) is clinically used as the only T-cell modifier available for rheumatoid arthritis treatment and has shown similar efficacy as tumour necrosis factor inhibitors and a safer profile, especially...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have